WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Computer Hardware Saturday, March 7, 2026 
Add Press Release News | News Feeds Feeds | Email This News Email


Glytec Named Top Diabetes Management Platform for 2025
Saturday, September 20, 2025

Recognition by Healthcare Tech Outlook underscores Glytec's leadership in hospital insulin management, clinical outcomes, and enterprise scalability

BOSTON, Sept. 16, 2025 /PRNewswire/ -- Glytec, the leading provider of an AI-powered diabetes platform for hospitals and health systems, today announced that Healthcare Tech Outlook named Glytec its Top Diabetes Management Platform for 2025. The annual award recognizes technologies that advance patient safety, streamline clinical workflows, and deliver measurable outcomes at scale.

"Earning Healthcare Tech Outlook's top honor validates the hard work our teams and hospital partners put in every day," said Patrick Cua, CEO of Glytec. "Glucommander is purpose?built to help clinicians administer insulin more safely and easily, and this recognition reflects the difference it makes for patients across the continuum of care."

At the core of Glytec's cloud-based platform is Glucommander, the FDA-cleared insulin dosing software that helps clinicians personalize IV and subcutaneous insulin therapy. Surrounding capabilities, including workflow support tools, analytics, enterprise integration, and managed security, further reduce the IT burden for hospitals and help deliver safe, effective, and scalable glycemic management.

Why this recognition matters

    --  Comprehensive Solution: Glucommander supports IV insulin, subcutaneous
        insulin, and transitions, providing step-by-step guidance, alerts, and
        decision support tools to help streamline nursing workflows.


    --  Hospital and Patient Impact: More than one-third of hospitalized
        patients require insulin therapy during their stay. Each year, more than
        2 million patients experience hypoglycemia-related adverse events in the
        hospital. According to the Agency for Healthcare Research and Quality
        (AHRQ), these events contribute to more than $8 billion in costs.
    --  Immediate Return on Investment: Glucommander helps achieve fewer
        hypoglycemic events, shorter hospital stays, reduced readmissions, and
        an average 6x-8x return on investment within the first 3 months.

Customer momentum

Community, academic, and IDN health systems use Glucommander® to elevate glycemic care in intensive care units, perioperative settings, medical?surgical floors, and specialty areas. Recent initiatives include:

    --  Standardizing IV?to?SC (subcutaneous) transitions with clinical pathways
        supported by Glucommander's decision logic and rounding workflows.


    --  Empowering nurses and clinicians with simplified order sets, timers,
        alerts, guardrails, and real?time insights.
    --  Leveraging analytics to track glycemic KPIs, drive financial returns,
        and sustain clinical improvements across sites.

About Glytec

Glytec's industry-leading, AI-driven technology platform, trusted by more than 400 hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing hospital length of stay and readmissions, and optimizing clinical workflows. Its flagship solution, Glucommander®, the first-ever FDA-cleared cloud-based insulin management software, integrates seamlessly with EHRs and provides advanced clinical decision support, workflow alerts, patient monitoring, and comprehensive analytics. Supported by industry awards and more than 100 patents and 100 peer-reviewed publications, Glytec is dedicated to improving care from the hospital to the home for patients, providers, and payers. For more information, visit www.glytec.com or follow Glytec on LinkedIn.

About Healthcare Tech Outlook

Healthcare Tech Outlook is a technology publication that highlights innovative solutions and industry leaders advancing healthcare delivery. Its annual awards recognize companies pushing the boundaries of clinical excellence, operational efficiency, and patient experience.

Media Contact:
Glytec PR Team
glytecpr@glytec.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/glytec-named-top-diabetes-management-platform-for-2025-302558017.html

SOURCE Glytec, LLC



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Energy Toolbase Launches Energy Storage Partnership with Sungrow to Support PowerStack 255CS and PowerTitan 2.0 | Jan 22, 2026
Nav Fresco Raises EUR15m Series C to Power the Future of AI-Driven Cooking and the Connected Kitchen Ecosystem | Jan 22, 2026
Nav No Assembly Required: Barrett Distribution Centers Powers Maxwood Furniture's West Coast DTC Expansion | Jan 22, 2026
Nav MetaOptics to Showcase Five Breakthrough Metalens-Powered Products at CES 2026 | Jan 22, 2026
Nav SCAILIUM Debuts "AI Production Layer" to Overcome GPU Starvation and Slash AI Energy Waste | Jan 22, 2026
Nav RS now offers Phoenix Contact's pioneering new NearFi technology | Jan 22, 2026
Nav Daikin Applied Invests $163M in Advanced R&D Test Lab to Bolster HVAC Innovation for Data Centers and Beyond | Jan 22, 2026
Nav Einride and IonQ Partnership Uses Quantum Computing to Optimize the Logistics of Electric and Autonomous Freight | Jan 22, 2026
Nav Hesai Recognized as the Only Lidar Company on Morgan Stanley's "Humanoid Tech 25" of Global Robotics Leaders | Jan 22, 2026
Nav Lumana Surpasses 50,000 Cameras, Cementing Its Leadership in AI Video Surveillance | Jan 22, 2026
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News